Reata Pharmaceuticals Inc (RETA)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
Yesterday 4:03 PM
View: 
Wilson Jason Douglas
Executive VP of Operations
Reata Pharmaceuticals Inc (RETA) Yesterday Sale (Planned) 15,000$146.13$2,191,960.00(67%)
22.35K to 7.35K
Yesterday 4:03 PM
View: 
Wilson Jason Douglas
Executive VP of Operations
Reata Pharmaceuticals Inc (RETA) Yesterday Conversion 15,000----204%
7.35K to 22.35K
Yesterday 4:03 PM
View: 
Wilson Jason Douglas
Executive VP of Operations
Reata Pharmaceuticals Inc (RETA) 14-Oct-19Sale (Planned) 15,000$100.00$1,500,000.00(67%)
22.35K to 7.35K
Yesterday 3:52 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 14-Oct-19Sale (Planned) 3,000$105.00$315,000.00(20%)
14.93K to 11.93K
Yesterday 4:03 PM
View: 
Wilson Jason Douglas
Executive VP of Operations
Reata Pharmaceuticals Inc (RETA) 14-Oct-19Conversion 15,000----204%
7.35K to 22.35K
Yesterday 3:52 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 14-Oct-19Conversion 3,000----25%
11.93K to 14.93K
Yesterday 3:52 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 11-Oct-19Conversion 9,795----458%
2.14K to 11.93K
30-Sep-19 3:18 PM
View: 
Huff James Warren
Chief Executive Officer
Director
Reata Pharmaceuticals Inc (RETA) 27-Sep-19Sale 63,000$86.61$5,456,120.00(36%)
172.82K to 109.82K
30-Sep-19 3:18 PM
View: 
Huff James Warren
Chief Executive Officer
Director
Reata Pharmaceuticals Inc (RETA) 23-Sep-19Gift 12,500----7%
179.82K to 192.32K
30-Sep-19 3:18 PM
View: 
Huff James Warren
Chief Executive Officer
Director
Reata Pharmaceuticals Inc (RETA) 23-Sep-19Gift 19,500----(10%)
192.32K to 172.82K
10-Sep-19 3:46 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 06-Sep-19Sale (Planned) 2,000$85.00$170,000.00(48%)
4.14K to 2.14K
10-Sep-19 3:46 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 06-Sep-19Conversion 2,000----94%
2.14K to 4.14K
16-Aug-19 3:09 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Aug-19Sale (Planned) 4,000$72.68$290,735.00(100%)
4.0K to 0
16-Aug-19 3:09 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Aug-19Conversion 4,000----100%
0 to 4.0K
17-Jul-19 1:01 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Jul-19Conversion 4,000----100%
0 to 4.0K
17-Jul-19 1:01 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Jul-19Market Sale (Planned) 4,000$84.64$338,556.00(100%)
4.0K to 0
19-Jun-19 4:06 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 17-Jun-19Conversion 4,000----100%
0 to 4.0K
19-Jun-19 4:06 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 17-Jun-19Market Sale (Planned) 4,000$83.54$334,177.00(100%)
4.0K to 0
05-Jun-19 1:10 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 03-Jun-19Conversion 2,000----94%
2.14K to 4.14K
05-Jun-19 1:10 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 03-Jun-19Market Sale (Planned) 2,000$85.20$170,400.00(48%)
4.14K to 2.14K
17-May-19 11:47 AM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-May-19Conversion 4,000----100%
0 to 4.0K
17-May-19 11:47 AM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-May-19Market Sale (Planned) 4,000$89.91$359,631.00(100%)
4.0K to 0
16-Apr-19 2:21 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Apr-19Conversion 4,000----100%
0 to 4.0K
16-Apr-19 2:21 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Apr-19Market Sale (Planned) 4,000$83.82$335,262.00(100%)
4.0K to 0
09-Apr-19 5:24 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 08-Apr-19Conversion 2,000----94%
2.14K to 4.14K
09-Apr-19 5:24 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 08-Apr-19Market Sale (Planned) 2,000$90.17$180,340.00(48%)
4.14K to 2.14K
21-Mar-19 3:23 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 19-Mar-19Conversion 28,396----100%
0 to 28.4K
21-Mar-19 3:23 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 19-Mar-19Market Sale 28,396$93.51$2,655,210.00(100%)
28.4K to 0
19-Mar-19 5:32 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 18-Mar-19Conversion 1,604----100%
0 to 1.6K
19-Mar-19 5:32 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 18-Mar-19Market Sale 1,604$95.11$152,556.00(100%)
1.6K to 0
19-Mar-19 5:32 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Mar-19Conversion 4,000----100%
0 to 4.0K
19-Mar-19 5:32 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Mar-19Market Sale (Planned) 4,000$93.62$374,470.00(100%)
4.0K to 0
07-Mar-19 5:12 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 05-Mar-19Market Sale 3,588$102.00$365,976.00(63%)
5.73K to 2.14K
07-Mar-19 5:22 PM
View: 
Wortley Michael D
Chief Legal Officer
Reata Pharmaceuticals Inc (RETA) 05-Mar-19Conversion 26,940----100%
0 to 26.94K
07-Mar-19 5:12 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 05-Mar-19Conversion 3,588----168%
2.14K to 5.73K
07-Mar-19 5:05 PM
View: 
Bass James Edward
Director
Reata Pharmaceuticals Inc (RETA) 05-Mar-19Gift 2,631----(2%)
113.57K to 110.94K
07-Mar-19 5:05 PM
View: 
Bass James Edward
Director
Reata Pharmaceuticals Inc (RETA) 05-Mar-19Market Sale 5,852$100.29$586,920.00(5%)
110.94K to 105.08K
07-Mar-19 5:22 PM
View: 
Wortley Michael D
Chief Legal Officer
Reata Pharmaceuticals Inc (RETA) 05-Mar-19Market Sale 26,940$100.17$2,698,440.00(100%)
26.94K to 0
27-Feb-19 4:22 PM
View: 
Ward Keith Wayne
Chief Development Officer
Reata Pharmaceuticals Inc (RETA) 26-Feb-19Conversion 25,184----292%
8.62K to 33.8K
27-Feb-19 4:22 PM
View: 
Ward Keith Wayne
Chief Development Officer
Reata Pharmaceuticals Inc (RETA) 26-Feb-19Market Sale (Planned) 25,184$91.21$2,296,930.00(75%)
33.8K to 8.62K
27-Feb-19 4:22 PM
View: 
Ward Keith Wayne
Chief Development Officer
Reata Pharmaceuticals Inc (RETA) 25-Feb-19Market Sale (Planned) 15,183$91.00$1,381,650.00(64%)
23.8K to 8.62K
27-Feb-19 4:22 PM
View: 
Ward Keith Wayne
Chief Development Officer
Reata Pharmaceuticals Inc (RETA) 25-Feb-19Conversion 15,183----176%
8.62K to 23.8K
19-Feb-19 1:50 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Feb-19Conversion 4,000----100%
0 to 4.0K
19-Feb-19 1:50 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Feb-19Market Sale (Planned) 4,000$85.44$341,760.00(100%)
4.0K to 0
06-Feb-19 1:01 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 05-Feb-19Conversion 3,000----100%
0 to 3.0K
06-Feb-19 1:01 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 05-Feb-19Market Sale (Planned) 3,000$80.00$240,000.00(100%)
3.0K to 0
(8%)
04-Feb-19 3:53 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 01-Feb-19Conversion 865----100%
0 to 0.86K
04-Feb-19 3:53 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 01-Feb-19Market Sale (Planned) 865$80.00$69,200.00(100%)
0.86K to 0
(8%)
01-Feb-19 11:50 AM
View: 
Ward Keith Wayne
Chief Development Officer
Reata Pharmaceuticals Inc (RETA) 31-Jan-19Conversion 4,150----48%
8.62K to 12.77K
04-Feb-19 3:53 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 31-Jan-19Conversion 6,135----100%
0 to 6.13K